Pharmacy Federal Laws and Regulations

Size: px
Start display at page:

Download "Pharmacy Federal Laws and Regulations"

Transcription

1 Pharmacy Federal Laws and Regulations Chapter 2 1

2 Lesson 2.1 Major Federal Laws Affecting the Pharmacy Technician 1. Identify the major laws within which technicians need to work when performing nondiscretionary functions in a pharmacy. 2. Describe the implications of the Health Insurance Portability and Accountability Act (HIPAA). 2

3 Lesson 2.2 The Functions and Guidelines of the FDA and DEA 3. Define the functions of the Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA). 4. Describe the FDA reporting process for adverse reactions. 3

4 Lesson 2.2 The Functions and Guidelines of the FDA and DEA (cont d) 5. Explain the necessary forms and regulations used for controlled substances. 6. List the current laws pertaining to ordering controlled stock and required record keeping. 6a. Describe the reasoning behind the DEA drug diversion act. 4

5 Lesson 2.3 Responsibilities of the Pharmacy Technician 7. List who can prescribe medications/devices. 8. Explain the difference between technicians tasks and pharmacists responsibilities. 9. Perform the function of verifying a DEA number. 5

6 Lesson 2.3 Responsibilities of the Pharmacy Technician (cont d) 10. Explain the verification process for internet pharmacies. 11. Explain the OSHA guidelines as they pertain to pharmacy. 12. Explain which law prevails among state, federal, and local laws. 6

7 Introduction Practice of pharmacy is governed by series of laws, regulations, and rules enforced by federal, state, local government; institutions and pharmacy management. Technicians need to understand these laws for passing the PTCB Certification Exam and for employment. 7

8 FDA History FDA history is important with respect to pharmacy. FDA is under the direction of the department of Health and Human Services. Main function is to enforce guidelines for manufacturers to ensure the safety and effectiveness of medications. 8

9 Early History of the FDA Investigated the adulteration and misbranding of agriculture goods used for food and drugs. Ability to regulate and enforce was limited. In the 1930s, the FDA gained the right to inspect factories and control advertising of products. 9

10 Early History of the FDA (cont d) Food, Drug and Cosmetic Act prohibits misbranding and adulteration and ensures following information given to public: Ø Mandatory food labeling Ø Standards of Identity Ø Imitation foods Ø Nutritional information for special dietary foods Ø False or misleading statements about product 10

11 Amendments to the Federal Food, Drug & Cosmetic Act Durham-Humphrey Amendment (1951) made a distinction between prescription and over-the-counter drugs. This was a change/update to the law. With this amendment, the FDA had to establish the difference between RX (prescription) and OTC (over the counter) medications. All RX bulk bottles contain RX only. 11

12 Another Amendment to the Federal Food, Drug & Cosmetic Act Kefauver-Harris Drug Amendments (1962) ensured the safety and effectiveness of medications. This was another change/update to the law. FDA now requires drug companies to submit research (drug studies) proving their drug is both safe and effective before the drug can be sold. If found unsafe or not effective after it is released, FDA has the power to remove the drug from the market. 12

13 13

14 1976 Medical Device Amendments allows FDA to: Ø FDA can now regulate and approve medical devices Ø FDA can now recall ineffective/dangerous medical devices Ø ** remember dangerous means prescription 14

15 Orphan Drug Act Orphan Drug Act 1983 created expanded research and availability of new treatments of all rare diseases. 15

16 Description of Laws Act: A statutory plan passed by Congress or any legislature which is a bill until enacted and becomes law Amendment: A change in the original act or law 16

17 1906 Federal Food and Drug Act Enacted to stop the sale of inaccurately labeled drugs. Manufacturers were required to put truthful information on the label before selling their drug. Manufacturers had to prove their drug s effectiveness. 17

18 1914 Harrison Narcotic Act Enacted because of the excessive number of opium addicts in the United States. This act was to reduce the recreational use of opium. RX required for opium. Doctors had to register to write RX s for opium, they had to keep records that included when and why they prescribed opium for a patient. 18

19 1938 Food, Drug, and Cosmetic Act Was enacted because the earlier Food and Drug Act was not worded strictly enough & did not include cosmetics. Proves the legal status for the Food and Drug Administration (FDA) Manufacturers now must prove to the FDA that a drug is safe for use and provide directions on the label for safe use. All controlled substances were required to be labeled Warning: May be habit-forming. 19

20 1938 Food, Drug, and Cosmetic Act (cont d) Defined the exact labeling for products and defined misbranding and adulteration as being illegal Ø Misbranding = label is false or misleading Ø Adulteration = prepared or stored incorrectly Required drug companies to include package inserts and directions for safe use. Shortly after this ACT, the FDA identified certain drugs required prescriptions. The RX is born. 20

21 1951 Durham-Humphrey Amendment to the Food, Drug and Cosmetic Act This was a change/update to the Food, Drug and Cosmetic Act. Required the manufacturer s label to contain RX only or Caution: Federal law prohibits dispensing without a prescription. Made certain drugs require a doctor s order and supervision. Made the initial distinction between legend drugs (by prescription only), over-the-counter (OTC) medications, and non-legend drugs. 21

22 1962 Kefauver-Harris Amendments Attempts to ensure the safety and effectiveness of all new drugs. (safe and effective means it won t harm you and it works) Gives FDA authority to approve new drugs before they can be sold to patients. Drug companies must have well controlled studies that prove effectiveness. Prevented the sale of thalidomide in the United States because children were born with birth defects after usage in pregnancy. When people understood that the FDA saved the US people a huge tragedy (show picture), support for the FDA grew. Adverse drug effects must be reported to the FDA. 22

23 1970 Comprehensive Drug Abuse Prevention and Control Act The Drug Enforcement Agency (DEA) was formed to enforce the laws concerning controlled substances and their distribution. Established DEA Controlled Substance Schedules I-V. Schedule I most restrictive no medically accepted use in the US. Ø Heroin, Marijuana, Ecstasy, LSD Ø Show bulk controlled substance bottles and see pg 43 textbook. Ø Hydrocodone is now CII due to recent law change (2014)!!!! 23

24 Comprehensive Drug Abuse and Prevention Act Dr. Kapp to explain DEA Schedules - start from the bottom DEA Controlled Substance Schedule I = CI Ø No legal use/no prescriptions DEA Controlled Substance Schedule 2 = CII DEA Controlled Substance Schedule 3 = CIII DEA Controlled Substance Schedule 4 = CIV DEA Controlled Substance Schedule 5= CV Legend Drugs -> drugs that require a RX OTC drugs -> no prescription required 24

25 1970 The Poison Prevention Packaging Act (PPPA) Required all medications to be placed in containers with childproof caps or packaging. It is estimated that more than 1.4 million childhood deaths were prevented annually because of childproof caps. See page 31 BOX 2-2 Standard for child proofing is that 80% of children under 5 should not be able to open, but 90% of adults should be able to open. 25

26 Orphan Drug Act 1983 Background info It costs millions and can take over 10 years for a drug company to develop a new drug and get it approved Before this law, there was no incentive to research/develop drugs that aren t going to be widely used Only 1 in 5000 drugs make it to human testing Only 1 in 5 of those gets approved for use. 26

27 Orphan Drug Act of 1983 Drug companies won t make a ton of money on developing meds for rare diseases. Allows drug companies to bypass the lengthy time requirements of testing a new drug and the cost that accompanied them to provide a medication to persons who had rare disease(s) (disease that affects 1 in every 200,000 people). US Government will give tax credits and possibly research money to companies willing to explore new treatments for rare diseases. 27

28 1987 Prescription Drug Marketing Act (PDMA) Helps to avoid counterfeit drugs and ingredients in the supply chain. Each drug has a pedigree (a record that it comes through all proper channels manufacturer to wholesaler to retailer or hospital) Limits diversion of pharmaceutical samples and prescription drugs. Diversion is the intentional misuse of a drug 28

29 1990 Omnibus Budget Reconciliation Act (OBRA 90) OBRA 90 is a law that specifically must be followed by pharmacists. The US government helps pay the medical costs for Medicare (elderly) and Medicaid (poor) patients. California s Medicaid program for the poor is called MediCAL. (Show cards) Congress made this law to address poor health care quality for the elderly. Quality improved dramatically when a pharmacist provided consultation to the patient. 29

30 OBRA 90 second slide Pharmacists must check the patient s drug profile and make sure all new drugs are compatible with what the patient is already taking. So the government decided they would require this consultation in the hopes of better health care and to ultimately save the government money because people were taking their meds correctly. In a community pharmacy there is a system that identifies new prescriptions. If the TCH does not call the pharmacist over to consult the patient, they are breaking the law. 30

31 1990 Omnibus Budget Reconciliation Act (third slide) States that a pharmacist must counsel (at the time of purchase) all Medicare and Medicaid patients who receive new prescriptions. All patients must be given information on the drug that they are taking, its name, when to take it, how long to take it, and any side effects or possible interactions. Many states, including California, adopted OBRA to apply to all new prescriptions; federal law deals only with Medicare and Medicaid. 31

32 Health Insurance Portability and Accountability Act of 1996 (HIPAA) Deals with a patient s right to privacy of their protected health information (PHI). Changes for pharmacy: Upon first visit to a pharmacy (or doctor s office) the privacy policy is provided and the patient must sign it. Keeps privileged information about a customer from being disclosed without his or her consent. This is why you must be 18 to work as a TCH. You must be held accountable for HIPAA 32

33 What Does this Mean for the Pharmacy? The physician can call and request information on his/her patient. The patient s health insurance company can request information. Information can be shared with patients about their own coverage or medications. If a spouse or parent wants info, it gets tricky. 33

34 How is Information Protected via the Computer? To avoid private information being hacked, encryption is required. Encryption converts the information into a nonreadable format. So when we type a prescription and bill the insurance company, the request is encrypted. 34

35 What are the Rights of the Patient? Ask to see and get a copy of your health records. (Mail other family members over 18 - Dr. Kapp explain) Have corrections added to your health information. Receive a notice that tells you how your health information may be used and shared. (this is provided in the privacy policy given upon first visit) 35

36 What are the Rights of the Patient? (cont d) Decide if you want to give your permission before your health information can be used or shared for certain purposes, such as for marketing. Get a report on when and why your health information was shared for certain purposes. 36

37 What are the Rights of the Patient? (cont d) If you believe your rights are being denied or your health information isn t being protected, you can: Ø File a complaint with your provider or health insurer. Ø File a complaint with the U.S. Government. 37

38 Examples of what a Technician CANNOT Do Give out any personal or medical information pertaining to the patient to any entity not covered under HIPPA Share any information with any family member or friend, coworker, manager, or any entity not covered under HIPAA Have students volunteer to read each example in Box 2-3, page 34 38

39 Who can info be shared with? PHI (private health info) may be disclosed to: Ø Law Enforcement Ø Public health authorities like the BOP or CDC Ø Entities subject to FDA regulation Ø Those who have been exposed to a communicable disease Ø Employers regarding work-related illness/injury in order to comply with OSHA Ø Insurance company Ø Patient s Doctor or doctor s office Read Examples 1-3 page 35 39

40 Law Enforcement Purposes PHI may be disclosed to law enforcement, including: Ø As required by law, such as court orders Ø To identify or locate a suspect, fugitive, material witness, or missing person Ø Information about a victim Ø If criminal activity caused a victim s death Ø Take a minute to read the examples on page 35 near the bottom. 40

41 2000 Drug Addiction Treatment Act (Data 2000) Allows doctors to prescribe drugs in schedule CIII-CV for patients suffering from opioid addiction to help the patient detox. Patient must be in a treatment program and doctor must have special detox training. Review the types of medications Ø Controlled substances (DEA Schedule I-V) Ø Legend drugs = prescription (RX drugs) Ø Behind the Counter (BTC): Sudafed and Plan B Ø Over the Counter (OTC) Ø Herbals not FDA approved 41

42 2003 Medicare Modernization Act (MMA) Before this Act, Medicare (elderly) did not cover medications which could be quite expensive. MMA provides a drug discount card or prescription insurance plan. Also known as Medicare Part D. Medicare Advantage is the name of the most current program offering drug discount benefits due to low income. 42

43 2005 Combat Methamphetamine Act Bill addresses all areas of manufacturing, law enforcement, and sale of pseudoephedrine (sudafed), which is used as an ingredient in the preparation of methamphetamine. All pseudoephedrine containing products must be sold behind the counter (BTC) and only by a licensed pharmacist or technician. Sale is limited and the cash register will step you through the process. In the TV show Breaking Bad they were trying to make methamphetamine. 43

44 Drug Listing Act of 1972 Amendment to Food, Drug and Cosmetic Act Page 38 box 2-1 Amends Food, Drug and Cosmetic Act and prevents unfair or deceptive packaging and labeling. ESTABLISHES THE NATIONAL DRUG CODE NUMBER = NDC# NDC number XXXXX-YYYY-ZZ The first group of 5 numbers is assigned by the FDA. Each manufacturer has its own unique first 5 digits given to them by the FDA. 44

45 Obamacare = The Affordable Care Act (ACA) of 2010 Too many uninsured in the US. Those with insurance pay more to help cover the costs of those uninsured. US Government votes to require everyone has insurance or pay a fine each year when they pay income taxes. Hope is that if everyone is covered the costs go down for everyone. 45

46 Affordable Care Act (ACA) slide 2 Benefits Include Ø Pre-existing conditions are covered Ø You can stay on your parents insurance until age 26!! Ø Insurance cannot drop you once they spend a certain amount on you. Ø Men and women need to be charged the same amount. Women use to pay more for insurance. Ø Free annual check up (insurance cannot charge a copay) Ø California s program under the ACA is called Covered California. 46

47 ACA slide 3 Disadvantages Ø Tax penalty if you do not have coverage Ø The website to sign up was not working when promised so politically it made Obama look bad. Obamacare (ACA) is highly politicized. Many democrats and many republicans like that their kids can stay on their insurance, that pre-existing conditions are covered, and that the insurance cannot kick you off once they spend a certain amount of you. As we have seen amendments to other laws, both parties warn that they would like to add improvements to the ACA. 47

48 FDA/DEA Chapter 2.2 DEA was created under the Department of Justice. Its function is to prevent the illegal distribution and misuse of narcotics (controlled substances). The DEA issues licenses to practitioners, pharmacies, and manufacturers of controlled substances. Both agencies can work together if the drug is a controlled substance. National Drug Code (NDC) page digits

49 FDA Reporting Process and Adverse Reactions There is toll-free number (1-800-FDA-1088) for reporting any defect found in OTC medications and any other drug problems. MedWatch Any medication reaction that might cause disability, hospitalization, or death should be reported. Patient s identity must be kept confidential. 49

50 FDA Reporting Process and Adverse Reactions (cont d) MedWatch: program under the FDA that allows consumers and healthcare professionals to report any discrepancies in medication or adverse reactions to medications. See Figure 2-3 page

51 Recalled Drugs Three classes of recalls: Ø Class 1: Products that could cause serious or even fatal harm Ø Class 2: Products found to cause a temporary health problem or a slight threat of serious harm Ø Class 3: Products that may have a minor defect or other condition that would not harm the patient As a clerk, TCH or intern you may be pulling recalled lot numbers as a regular part of your job. 51

52 Controlled Substances Are commonly known as narcotics and are addictive. Relaxants. Narcotics are derived from opium or opium-like substances. Opium comes from the poppy seed plant and has analgesic effects and also affects mood and behavior. 52

53 Controlled Substances (cont d) Opioids, such as codeine and morphine, are substances created from opium. Each type of narcotic is assigned a rating that depends on its addiction and abuse potential. 53

54 Ratings of Scheduled (Controlled) Substances Letter C, meaning controlled substances, is used in addition to Roman numerals to indicate the addictiveness or abuse potential of narcotics. Five levels based on potential for abuse. C-I: strongest potential for abuse; no medicinal use in the United States (e.g., LSD, heroin) 54

55 Ratings of Schedules (Controlled) Substances (cont d) C-II, C-III, C-IV, C-V: all medicinal narcotic drugs C-V: kept OTC in some states because of low potential abuse NOT IN CALIFORNIA C-II: must be locked up because of high potential abuse Attorney General decides under which schedule to place a drug Refer to Table 2-2 (Page 43), Typical Controlled Substances. Hydrocodone is now CII!!!! 55

56 Tamper-Proof Prescriptions New scripts have up to 8 different tamper-proof security marks on them. Ø Prevents forgery and fraud. See page 45 56

57 Registration Required for Maintaining Narcotics DEA three main registration forms: Ø Form 224: needed by pharmacy to dispense controlled substances Ø Form 225: to manufacture or distribute controlled substances Ø Form 363: to run a narcotic treatment program or compound narcotics Ø **DEA 222 form is the form the pharmacy uses to order Schedule II narcotics. It is in triplicate. See picture and discuss page

58 Refilling Controlled Substances Strict guidelines C-III through C-V: can be refilled a maximum of five times within 6 months from the original order, whichever comes first. How is this different from a normal non-controlled prescription? Record must be kept with pharmacist s initials and date it was dispensed. 58

59 Ordering Controlled Substances Pharmacy obtains C-II substances from a distributor Form 222 must be filled out by the receiving pharmacy in pen, typewriter, or indelible pencil Top copy and middle copy with carbon paper are sent to the supplier or manufacturer Doctors, pharmacies, and drug wholesalers all have their own DEA numbers 59

60 Ordering Controlled Substances (cont d) Top and middle copy with carbon paper: returned to distributor or wholesaler Filing electronically is also possible but not for CI or CII Pharmacy retains bottom copy Invoice and form retained for 7 years 60

61 Ordering Controlled Substances (cont d) C-III, C-IV, C-V: ordered on normal invoice forms but must be filed and retained for DEA or BOP inspection Schedule II should be kept separate from other nonscheduled drugs usually in a locked cabinet. Forms kept for 2 years (federal) 61

62 Ordering Controlled Substances (cont d) Receipt of controlled substances: pharmacist compares copy of Form 222 to invoice Both copies signed for accuracy Errors: forms become invalid; cannot be erased or thrown away 62

63 Record Keeping Three Methods of Filing Controlled Substances and Legend Drugs (Table 2-4) System Drawer 1 Drawer II Drawer III 1 C-II C-III All other separate through C-V prescriptions 2 C-II C-III C-V* and separate all legend drugs 3 C-II All other through C-V* prescriptions *If any C-III, C-IV, or C-V controlled drugs are kept with noncontrolled drugs (System 2) or mixed with C-II drugs (System 3), they must be stamped with a red C for easy identification. All records must be kept on site for no less than 2 years. Many states, however, have longer requirements for keeping records; remember the strictest law is the one that must be followed. When taking inventory, you must have exact counts of C-II controlled substances at all times. The final count can be inventoried only by a licensed pharmacist. 63

64 Narcotic Inventory Perpetual inventory Pharmacist must validate all counts if done by a technician. Discrepancies will be investigated by DEA. 64

65 Reverse Distributor All controlled substances that are unwanted, unusable, or outdated that are returned to the distributor Ø Prevents misuse of drugs = drug diversion 65

66 Filling, Refilling, and Transferring Prescriptions for Controlled Drugs Original Fill of CII Through CV: written, oral, or fax Emergency CII Original Fill: oral order only in emergency situations Refills of CII Through CV: Ø CII: no refills Ø CIII and CIV: 5 times within 6 months (120 days in California) Ø CV: no restrictions = up to a year from the date it was written. 66

67 Filling, Refilling, and Transferring Prescriptions for Controlled Drugs (cont d) Partial Filling of CII Through CV: Ø CIII, IV, and V must have remainder dispensed within 6 months. Ø CII must have remainder dispensed within 72 hours. Transfer of Controlled Drug Prescription CII Through CV: may only be transferred once. 67

68 Filling, Refilling and Transferring Prescriptions for Controlled Drugs (cont d) Some states require Schedule V drugs to be dispensed by pharmacist. (California) Controlled Substances CII Through CV may be mailed as long as contents are not identified on packaging. 68

69 Monographs/Package Inserts Can be found online. Can be found in stock bottle. Contains the following: description, clinical pharmacology, indications and usage, contraindications, warnings, precautions, drug abuse and dependence, adverse reactions, dosage, and how supplied. See monograph on page 56/57. Boxed Warning required on monographs for meds that carry a high risk potential. Medguides describe. 69

70 Pregnancy Categories pages 58 and 59 See box 2-9 on page 59 End lecture

71 Prescription Regulations Start 2.3 Who can prescribe? FDA and DEA have no authority in determining prescribers. Prescribers are licensed by their individual state boards. (Medical Board of CA, CA State Board of Pharmacy) Standard practitioners in all 50 states are physicians, surgeons, doctors of osteopathy, dentists, podiatrists, veterinarians, and optometrists. 71

72 Who Can Receive a Prescription? Pharmacy technicians take in prescriptions, interpret them, and fill them. Technicians cannot take telephone RXs. Pharmacists give the final check, take verbal telephone orders, and transfer prescriptions to another pharmacy. 72

73 73

74 Prescription Labels The information on a prescription label differs from a prescription order. Two necessary components are pharmacy information and patient information. Special labeling sometimes required because of adverse effects or possibility of teratogenicity on an unborn fetus. This section of the book is worth reading (p.60-61) in figure 2-9 look at the prescription order versus the RX label. 74

75 Records and Labeling Requirements Regulated by state law Table 2-5 page 62 75

76 Repackaging Medication taken from bulk packages and placed into blister packs or unit-dosing devices must include: Ø Drug name Ø Strength and dosage form Ø Manufacturer and lot number Ø Expiration date 76

77 DEA Verification All prescribers must be registered with the DEA to write prescriptions for controlled substances. Prescribers are given a nine-character identification code, which is different for each prescriber. Pharmacies have DEA numbers as well. 77

78 DEA Verification (cont d) First two characters are letters: A or B followed by first letter of prescriber s last name. Next seven digits are composed of numbers added together. Refer to Box 2-12 page 63, DEA Verification Process. (This will be tested!! Final too!!) Memorize and do not forget these 6 steps. 78

79 Non-Child-Resistant Caps Medications are required to be packaged in containers that are exceptionally hard for children to open. Adults can request no childproof caps. Pharmacy keeps information on patient s record and might require a signed release form. 79

80 Special Prescribing Programs Programs for opioid maintenance: Ø Methadone maintenance treatment Ø Suboxone & Subutex Risk management programs for prescription drugs: Ø ipledge Program (Accutane) Ø This drug is so toxic to unborn fetuses that a pregnancy test is required before the doctor can authorize a refill. It is like a CII in the sense that no refills are allowed. It requires a new RX q time. 80

81 Pharmacy Sites Brick-and-mortar stores (community pharmacy). Mail-order pharmacies E-pharmacies (online pharmacies) Ø National Association of Boards of Pharmacies accredits them Ø Potential for illegally-ordered drugs 81

82 Occupational Safety and Health Administration (OSHA) Oversees workplace safety. Materials Safety Data Sheets must be available for all chemicals. Includes information on storage requirements, handling, and what to do in case of a spill or contact with eyes. 82

83 The Joint Commission previously JCAHO Mission is to improve the safety and quality of care via accreditation of healthcare organizations. Areas of concern: how look-alike, sound-alike drugs are identified; how communication, allergy notification, conflicting prescriptions, verbal orders and other areas that may create an avenue for errors are handled. Must be accredited q 3 years. 83

84 State Laws Each state has its own set of laws that must be followed by all employees in the pharmacy. States have laws that differ from federal law. The strictest law is the one that must be followed. 84

85 Liabilities Tort: causing injury to a person intentionally or because of negligence Negligence: an action taken without the forethought that should have been taken by a reasonable person; a mistake 85

86 Liabilities (cont d) Intentional mistake: penalty ranges from criminal charges to awarding of damages Negligent mistake: affect employment and can result in punitive damages Be aware of rights and responsibilities. 86

87 Pharmacy Employee Requirements: Request for Waiver A pharmacy must apply for a waiver from the DEA in order to employ someone: Ø Who has been convicted of a felony related to drugs Ø Who has had DEA application for registration revoked, surrendered, or denied 87

Do not open the test booklet prior to being told to do so.

Do not open the test booklet prior to being told to do so. Last Name: Pharmacy 4054 Pharmacy Law Exam II Do not open the test booklet prior to being told to do so. I, the undersigned student, agree to do my best on the exam and that I have only used resources

More information

Changes to the Eighth Edition

Changes to the Eighth Edition Pharmacy Practice and the Law, Eighth Edition Includes Navigate 2 Advantage Access By Richard R. Abood, BS Pharm, JD-Professor Emeritus Pharmacy Practice, Thomas J. Long School of Pharmacy and Health Sciences,

More information

This Chapter Contains:

This Chapter Contains: This Chapter Contains: State and Federal Laws Relating to Controlled Substances and Other Medications Drugs Used in Animal Shelters Acquiring Controlled Substances Record Keeping of Controlled Substances

More information

Guideline for the Rational Use of Controlled Drugs

Guideline for the Rational Use of Controlled Drugs Guideline for the Rational Use of Controlled Drugs Ministry of Health Male' Republic of Maldives April 2000 Table of Contents Page Introduction.. 2 1. Procurement and Supply of Controlled Drugs 3 1.1 Import

More information

Cengage Learning. All rights reserved. No distribution allowed without express authorization. PART 1. Introduction to Pharmacologic Principles

Cengage Learning. All rights reserved. No distribution allowed without express authorization. PART 1. Introduction to Pharmacologic Principles PART 1 Introduction to Pharmacologic Principles 80333_01_ch01_p001-011 pp3.indd 1 5/5/10 9:51:20 PM Chapter 1 Consumer Safety and Drug Regulations Objectives Upon completion of this chapter, the learner

More information

PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION October 29, 1998

PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION October 29, 1998 PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION October 29, 1998 Questions 1 20 are multiple choice; please record answers on Side 2 of a Standard Answer Sheet, Form 1158. Follow the instructions

More information

Controlled Substance Prescribing: A Physician s Guide. Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System

Controlled Substance Prescribing: A Physician s Guide. Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System Controlled Substance Prescribing: A Physician s Guide Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System Objectives Review schedules of controlled substances and their propensity for

More information

RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS

RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER 1140-17 DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS 1140-17-.01 Definitions 1140-17-.02 Purpose 1140-17-.03 Eligibility Criteria for Program Participation

More information

Use of Controlled Substances in Research.

Use of Controlled Substances in Research. 3341-7-09 Use of Controlled Substances in Research. Applicability Faculty and staff who hold federal Drug Enforcement Administration (DEA) licenses to use controlled substances for research purposes. Responsible

More information

CHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY

CHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY CHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY COMMUNITY PHARMACY OPERATIONS Technician Duties Related to Dispensing Over-the-Counter Drugs and

More information

LUNCH AND LEARN. January 8, CE Activity Information & Accreditation

LUNCH AND LEARN. January 8, CE Activity Information & Accreditation LUNCH AND LEARN Pharmacy Law: The Ins and Outs of Controlled Substances January 8, 2016 Featured Speaker: Joseph J. Bogdan, Pharm.D., R.Ph., J.D. Pharmacist Attorney Lisle, Illinois 1 CE Activity Information

More information

Controlled Substance Prescribing and Diversion. Pamela Polk, R. Ph., Inspector DHEC Bureau of Drug Control

Controlled Substance Prescribing and Diversion. Pamela Polk, R. Ph., Inspector DHEC Bureau of Drug Control Controlled Substance Prescribing and Diversion Pamela Polk, R. Ph., Inspector DHEC Bureau of Drug Control In 2010, approximately 38,329 unintentional drug overdose deaths occurred in the United States,

More information

Which was the greatest problem with patent medicines in early America that lead to drug legislation?

Which was the greatest problem with patent medicines in early America that lead to drug legislation? Pharmacology Connections to Nursing Practice 3rd Edition Adams Test Bank Full Download: http://testbanklive.com/download/pharmacology-connections-to-nursing-practice-3rd-edition-adams-test-bank/ Adams

More information

Student Number. PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION 2 November 10, 1999

Student Number. PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION 2 November 10, 1999 PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION 2 November 10, 1999 Questions 1-25 are multiple choice; please record answers on Side 2 of a Standard Answer Sheet, Form 1158. Follow the instructions

More information

SECTION PRESCRIPTIONS

SECTION PRESCRIPTIONS SECTION.1800 - PRESCRIPTIONS 21 NCAC 46.1801 EXERCISE OF PROFESSIONAL JUDGMENT IN FILLING PRESCRIPTIONS (a) A pharmacist or device and medical equipment dispenser shall have a right to refuse to fill or

More information

PART 1306 PRESCRIPTIONS. 21 CFR Ch. II ( Edition)

PART 1306 PRESCRIPTIONS. 21 CFR Ch. II ( Edition) 1305.16 1305.16 Special procedure for filling certain order forms. (a) The purchaser of carfentanil etorphine hydrochloride or diprenorphine shall submit copy 1 and 2 of the order form to the supplier

More information

Sub. S.B. 119 As Passed by the Senate

Sub. S.B. 119 As Passed by the Senate AM3404 Sub. S.B. 119 As Passed by the Senate Topic: Opioid Data and Communication Expansion Act moved to amend as follows: In line 1 of the title, after "4723.52," insert "4729.01, 4729.44, 4729.75, 4729.79,

More information

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Fundamentals of Pharmacology for Veterinary Technicians Chapter 1

Fundamentals of Pharmacology for Veterinary Technicians Chapter 1 1906 1914 1933 1937 1938 1941 1951 1965 1968 1970 1970 1972 1972 1983 1984 1988 1994 1994 1996 1997 2001 2003 2008 The original Pure Food and Drug Act is passed by Congress on June 30 and signed by President

More information

Professional Should Know

Professional Should Know Chapter : Law and Ethics: What the Pharmacy Professional Should Know 3 Contact Hours By: Katie Ingersoll, RPh, PharmD, and Staff Pharmacist for a national chain. Author Disclosure: Katie Ingersoll and

More information

Controlled Substances Program. For Academic Units

Controlled Substances Program. For Academic Units Brigham Young University Page 1 Provo, Utah Controlled Substances Program For Academic Units Last Revised: November 30, 2009 Brigham Young University Page 2 TABLE OF CONTENTS Section Title Page 1.0 Overview

More information

Confirm Limit--Level of detectable drugs in urine to confirm a positive test.

Confirm Limit--Level of detectable drugs in urine to confirm a positive test. Alcohol and Substance Abuse Policy Purpose To establish and maintain a safe, healthy working environment for all PVFD members; reduce the incidence of accidental injury to members and property; reduce

More information

Chairwoman Bono Mack, Vice-Chairwoman Blackburn, Ranking Member Butterfield and

Chairwoman Bono Mack, Vice-Chairwoman Blackburn, Ranking Member Butterfield and United States House of Representatives Committee on Energy and Commerce Subcommittee on Commerce, Manufacturing and Trade Hearing on Chairwoman Bono Mack, Vice-Chairwoman Blackburn, Ranking Member Butterfield

More information

This presentation focuses on recent changes in vaccine storage and handling requirements for the State Childhood Vaccine Program.

This presentation focuses on recent changes in vaccine storage and handling requirements for the State Childhood Vaccine Program. This presentation focuses on recent changes in vaccine storage and handling requirements for the State Childhood Vaccine Program. 1 Universal vaccine policy since 1989 All children have access to vaccines

More information

FDA Laws & Pharmacy Practice

FDA Laws & Pharmacy Practice Objectives FDA Laws & Pharmacy Practice Tom Hazlet Pharmacy 543 October 6, 2004 Be able to discuss the evolution of food and drug law in the United States Be able to discuss the ways in which pharmacists

More information

Crowe Healthcare Webinar Series

Crowe Healthcare Webinar Series Crowe Healthcare Webinar Series Healthcare Providers Ongoing Challenges With Controlled Substances Presented by: Scott Gerard, Healthcare Risk Consulting Partner Eric Jolly, Healthcare Risk Vice President

More information

ORDINANCE NO

ORDINANCE NO To Enact New Chapter 765 Tobacco Sales of the Codified Ordinances of the City of Worthington to Require a License for the Sale of Tobacco and Prohibiting Tobacco Sales to Persons Under Twenty-One. WHEREAS,

More information

FDA Laws & Pharmacy Practice

FDA Laws & Pharmacy Practice Objectives FDA Laws & Pharmacy Practice Tom Hazlet Pharmacy 543 Autumn 2006 Be able to discuss the evolution of food and drug law in the United States Be able to discuss the ways in which pharmacists and

More information

e-cigarette Regulation

e-cigarette Regulation e-cigarette Regulation The Act prohibits the sale of electronic smoking devices and alternative nicotine products to minors, and requires child-resistant packaging for liquid nicotine containers. The Act

More information

Prescribing and Dispensing Drugs

Prescribing and Dispensing Drugs STANDARDS & GUIDELINES Prescribing and Dispensing Drugs TABLE OF CONTENTS Standards and guidelines inform practitioners and the public of CDSBC s expectations for registrants. This document primarily contains

More information

THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and

THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and effective. Before any drug is approved for marketing

More information

PRODUCTS: All products containing ephedrine (EPH) and pseudoephedrine (PSE). (IC )

PRODUCTS: All products containing ephedrine (EPH) and pseudoephedrine (PSE). (IC ) INDIANA PRODUCTS: All products containing ephedrine (EPH) and pseudoephedrine (PSE). (IC 35-48- 4-14.7) PRODUCT EXEMPTIONS: EPH or PSE products dispensed pursuant to a prescription (IC 35-48-4-14.7); Sale

More information

Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business

Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business to Facilitate Compliance with Regulations 5(1)(g), 6, 8 and 11 of the Regulation of Retail Pharmacy Businesses

More information

Test Bank for Basic Pharmacology for Nurses 14th edition by Clayton, Stock and Harroun

Test Bank for Basic Pharmacology for Nurses 14th edition by Clayton, Stock and Harroun Test Bank for Basic Pharmacology for Nurses 14th edition by Clayton, Stock and Harroun Link download full: https://digitalcontentmarket.org/download/testbank-for-basic-pharmacology-for-nurses-14thedition-by-clayton-stock-harroun

More information

CONDITIONS OF COMMUNITY SUPERVISION

CONDITIONS OF COMMUNITY SUPERVISION CASE NUMBER THE STATE OF TEXAS IN THE COUNTY CRIMINAL COURT V AT LAW NUMBER SPN OF HARRIS COUNTY, TEXAS CONDITIONS OF COMMUNITY SUPERVISION On this the day of, 2012, the defendant in the above-styled case

More information

HEB Pharmacy Conference October 25, 2014

HEB Pharmacy Conference October 25, 2014 Texas State Board of Pharmacy Laws and Rules Update Allison Benz, R.Ph., M.S. Director of Professional Services Central Texas Society of Health-System Pharmacists Annual Seminar October 25, 2014 Texas

More information

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Minnesota Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Nurse Practitioner Council New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) Peter Ryba, PharmD PMP Director

More information

The Role of the PDMP: Foundational Knowledge and Best Practices

The Role of the PDMP: Foundational Knowledge and Best Practices The Role of the PDMP: Foundational Knowledge and Best Practices Brent I. Fox, PharmD, PhD Health Outcomes Research and Policy Harrison School of Pharmacy Auburn University DISCLOSURE I, Brent Fox, have

More information

LEGAL ASPECTS of MEDICAL MARIJUANA Florida Nurse Practitioner Network Annual Conference September 17, 2018

LEGAL ASPECTS of MEDICAL MARIJUANA Florida Nurse Practitioner Network Annual Conference September 17, 2018 LEGAL ASPECTS of MEDICAL MARIJUANA Florida Nurse Practitioner Network Annual Conference September 17, 2018 DISCLAIMER The material presented is general legal information and is not legal advice. Specific

More information

ARKANSAS DEPARTMENT OF HEALTH

ARKANSAS DEPARTMENT OF HEALTH ARKANSAS DEPARTMENT OF HEALTH RULES AND REGULATIONS PERTAINING TO CONTROLLED SUBSTANCES (July 26, 2001) I, Jerry Jones, P.D., Director of Pharmacy Services and Drug Control for the Arkansas Department

More information

MARYLAND BOARD OF PHARMACY

MARYLAND BOARD OF PHARMACY MARYLAND BOARD OF PHARMACY CONTRACEPTION REGULATIONSAnd Other Legislative Initiatives THE ROAD FROM CONCEPTUALIZATION TO IMPLEMENTATION Deena Speights-Napata Executive Director Maryland Board of Pharmacy

More information

HIPAA FOR THE DENTAL PRACTICE

HIPAA FOR THE DENTAL PRACTICE HIPAA FOR THE DENTAL PRACTICE Catherine C. Cownie Adam J. Freed E-mail: cownie@brownwinick.com E-mail: freed@brownwnick.com Telephone: 515-242-2490 Telephone: 515-242-2402 BrownWinick Law Firm 666 Grand

More information

4543 Project Titles 1

4543 Project Titles 1 4543 Project Titles 1 GROUP UPDATE TITLE(S) 1 10/4 Diagnosis requirement on prescription Of all the requirements needed to be written on a prescription, there is no requirement to include the diagnosis.

More information

19 TH JUDICIAL DUI COURT REFERRAL INFORMATION

19 TH JUDICIAL DUI COURT REFERRAL INFORMATION 19 TH JUDICIAL DUI COURT REFERRAL INFORMATION Please review the attached DUI Court contract and Release of Information. ******* You must sign and hand back to the court the Release of Information today.

More information

Like others here today, we are very conflicted on the FDA s proposal on behind-thecounter medications, but thank you for raising the issue.

Like others here today, we are very conflicted on the FDA s proposal on behind-thecounter medications, but thank you for raising the issue. Statement of Consumers Union William Vaughan, Senior Policy Analyst before the US Food and Drug Administration Public Meeting on Behind the Counter Availability of Drugs November 14, 2007 Consumers Union

More information

PATIENT SIGNATURE: DOB: Date:

PATIENT SIGNATURE: DOB: Date: CINCINNATI PAIN PHYSICIANS, LLC (CPP) ACKNOWLEDGEMENT OF RECEIPT OF NOTICE OF PRIVACY PRACTICES By signing below, I acknowledge that I have received a copy of CPP s Notice of Privacy Practices. The Notice

More information

6/19/2012. Disappearing Drugs. Disappearing Drugs: Protect Yourself from Diversion. Disappearing Drugs: Protect Yourself from Diversion

6/19/2012. Disappearing Drugs. Disappearing Drugs: Protect Yourself from Diversion. Disappearing Drugs: Protect Yourself from Diversion Disappearing Drugs: Protect Yourself from Diversion Disappearing Drugs Mark Gann CEO Paladin Risk Control How long does diversion take? How long does diversion take? It only takes a few seconds to make

More information

4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch

4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch Libia Lugo Drug Specialist San Juan District Office Investigations Branch The Food and Drug Administration (FDA) responsibilities extend to the 50 United States, the District of Columbia, Puerto Rico,

More information

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Oklahoma Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite

More information

Chapter 1: Fundamentals of Pharmacology Test Bank

Chapter 1: Fundamentals of Pharmacology Test Bank Chapter 1: Fundamentals of Pharmacology Test Bank MULTIPLE CHOICE 1. By which of the following routes are drugs administered directly into the bloodstream? a. Enteral b. Transdermal c. Transmucosal d.

More information

Tracker e-prescribing 101. The Complete Guide

Tracker e-prescribing 101. The Complete Guide Tracker e-prescribing 101. The Complete Guide Copyright Stratum Access Technologies, Inc. 2017 www.stratumaccess.com Electronic prescribing, known in short as e-prescribing, is a method of prescription

More information

NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION

NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION Chapter NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION EFFECTIVE: Policy REVISED: 4/13/9 draft NALOXONE DISTRIBUTION POLICY I. PURPOSE: This New Mexico Department of Health (NMDOH)

More information

Counterfeit Medicinal Products. FINLAND Roschier, Attorneys Ltd.

Counterfeit Medicinal Products. FINLAND Roschier, Attorneys Ltd. Counterfeit Medicinal Products FINLAND Roschier, Attorneys Ltd. CONTACT INFORMATION Mikael Segercrantz Robert Hagelstam Roschier, Attorneys Ltd. Keskuskatu 7 A 00100 Helsinki, Finland 358.20.506.6000 mikael.segercrantz@roschier.com

More information

A Family Medicine Cabinet

A Family Medicine Cabinet A Family Medicine Cabinet What is a medicine? There is no generally accepted definition for the word medicine. Most people use the word medicine to refer to products that affect how the body functions.

More information

E. "Prospective employee": A person who has made application, whether written or oral, to CWI to become an employee.

E. Prospective employee: A person who has made application, whether written or oral, to CWI to become an employee. POLICY FOR A DRUG AND ALCOHOL-FREE WORKPLACE I. STATEMENT OF PURPOSE Crossroads of Western Iowa recognizes the problems of substance abuse in society and in the workplace. Substance abuse poses a serious

More information

December 2018 Brief Explanation of Proposition 2 and Compromise Bill Passage

December 2018 Brief Explanation of Proposition 2 and Compromise Bill Passage December 2018 Brief Explanation of Proposition 2 and Compromise Bill Passage You are probably already getting calls from patients about medical marijuana. You probably have many questions about how it

More information

Iowa District Court Polk County, Iowa. CARL OLSEN, ) ) Petitioner, ) ) vs. ) ) Docket No. CV IOWA BOARD OF PHARMACY ) ) Respondent.

Iowa District Court Polk County, Iowa. CARL OLSEN, ) ) Petitioner, ) ) vs. ) ) Docket No. CV IOWA BOARD OF PHARMACY ) ) Respondent. Iowa District Court Polk County, Iowa CARL OLSEN, ) ) Petitioner, ) ) vs. ) ) Docket No. CV 51068 IOWA BOARD OF PHARMACY ) ) Respondent. ) MEMORANDUM IN SUPPORT OF PETITION FOR JUDICIAL REVIEW Federal

More information

ARKANSAS STATE UNIVERSITY GOVERNING PRINCIPLES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH

ARKANSAS STATE UNIVERSITY GOVERNING PRINCIPLES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH ARKANSAS STATE UNIVERSITY GOVERNING PRINCIPLES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH 1.0 INTRODUCTION Arkansas State University (ASU) is committed to enhancing the growth of research and other

More information

Prescription Drug Take-Back Program Q s and A s

Prescription Drug Take-Back Program Q s and A s Got Drugs? Prescription Drug Take-Back Program Q s and A s What is the national drug take-back day? On Saturday, September 25 from 10:00 a.m. to 2:00 p.m., DEA and partner organizations will set up sites

More information

SUBSTANCE ABUSE MODEL POLICY

SUBSTANCE ABUSE MODEL POLICY SUBSTANCE ABUSE MODEL POLICY LUCAS R. AUBREY SHERMAN DUNN, P.C. WASHINGTON, D.C. AUBREY@SHERMANDUNN.COM OVERVIEW Why test? Is testing legal? Federal law State law Model Substance Abuse Policy and Program.

More information

AN ACT RELATING TO HEALTH CARE; ENACTING THE UNLICENSED HEALTH CARE BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO:

AN ACT RELATING TO HEALTH CARE; ENACTING THE UNLICENSED HEALTH CARE BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO: AN ACT RELATING TO HEALTH CARE; ENACTING THE UNLICENSED HEALTH CARE PRACTICE ACT; PROVIDING PENALTIES. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO: Section 1. SHORT TITLE.--This act may

More information

Prescription Medication Guidelines for Medical Providers in CorVel s CorCare and Care IQ Networks

Prescription Medication Guidelines for Medical Providers in CorVel s CorCare and Care IQ Networks Prescription Medication Guidelines for Medical Providers in CorVel s CorCare and Care IQ Networks Patient Health and Safety Guidelines Prescription Medications Policy Update / April 2017 In connection

More information

UNIVERSITY POLICY. Revised: Contact:

UNIVERSITY POLICY. Revised: Contact: UNIVERSITY POLICY Policy Name: Policy for Controlled Substances Section #: 90.2.3 Section Title: Compliance Approval Authority: Responsible Executive: Responsible Office: Formerly Book: President Adopted:

More information

Medicines and Cosmetics Regulation Unvalidated References:

Medicines and Cosmetics Regulation Unvalidated References: Medicines and Cosmetics Regulation 2002 Unvalidated References: This reprint of this Statutory Instrument incorporates all amendments, if any, made before 25 November 2006 and in force at 16 May 2002....

More information

Welcome to your. Pharmacy Services Guide. Many of our stores are open 24 hours. To find one near you, visit or call SHOP CVS.

Welcome to your. Pharmacy Services Guide. Many of our stores are open 24 hours. To find one near you, visit   or call SHOP CVS. Welcome to your Many of our stores are open 24 hours. To find one near you, visit www.cvs.com or call 1-800-SHOP CVS. Pharmacy Services Guide 06530RXS09 - Item #456748 11/08 Supplying you with health information

More information

Understanding the New Access to Cannabis for Medical Purposes Regulations

Understanding the New Access to Cannabis for Medical Purposes Regulations Understanding the New Access to Cannabis for Medical Purposes Regulations Health Canada August 2016 Table of Contents 1. Introduction 2. Health Canada's role 3. What it means for health care practitioners

More information

Physician Injectable Drug List (PIDL) Department for Medicaid Services, HP, and Magellan Rx Management June 1, 2010

Physician Injectable Drug List (PIDL) Department for Medicaid Services, HP, and Magellan Rx Management June 1, 2010 Physician Injectable Drug List (PIDL) Department for Medicaid Services, HP, and Magellan Rx Management June 1, 2010 Physician-Administered Drugs Physician-administered drugs are drugs, other than vaccines,

More information

Safe Medication Disposal A white position paper Pennsylvania Pharmacists Association February 8, 2009

Safe Medication Disposal A white position paper Pennsylvania Pharmacists Association February 8, 2009 Safe Medication Disposal A white position paper Pennsylvania Pharmacists Association February 8, 2009 Background and Situation Analysis: Consumers are rightly confused about what to do with their unwanted

More information

Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases

Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Overview On August 2, 2017, U.S. Attorney General Jeff Sessions announced a pilot program whereby a new federal data analysis program is being

More information

Presentation Overview

Presentation Overview Navigating the Changing Regulatory Enforcement Landscape Relating to Opioids Anna M. Grizzle Tizgel K.S. High Jerry Williamson, M.D. Presentation Overview Recent Enforcement Actions Physician s Perspective

More information

DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Apini$r$iy -tq 5-f

DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Apini$r$iy -tq 5-f DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Apini$r$iy -tq 5-f J Dallas District 4040 North Central Expressway Dallas, Texas 75204-3145 Ref: 2004-DAL-WL-03 WARNING LETTER CERTIFIED MAIL RETURN

More information

Renville County Tobacco Retailers Youth Tobacco Laws A TRAINING BY THE RENVILLE COUNTY PUBLIC HEALTH UPDATED NOVEMBER 2015

Renville County Tobacco Retailers Youth Tobacco Laws A TRAINING BY THE RENVILLE COUNTY PUBLIC HEALTH UPDATED NOVEMBER 2015 Renville County Tobacco Retailers Youth Tobacco Laws A TRAINING BY THE RENVILLE COUNTY PUBLIC HEALTH UPDATED NOVEMBER 2015 Training Goals Facts about Youth Tobacco Use Proper Identification Federal, State

More information

WELD COUNTY ADULT TREATMENT COURT REFERRAL INFORMATION

WELD COUNTY ADULT TREATMENT COURT REFERRAL INFORMATION WELD COUNTY ADULT TREATMENT COURT REFERRAL INFORMATION Please review the attached Adult Treatment Court contract and Authorization to Share Information. Once your case has been set on the adult treatment

More information

New Mexico. Prescribing and Dispensing Profile. Research current through November 2015.

New Mexico. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile New Mexico Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Medicines and You: A Guide for Older Adults

Medicines and You: A Guide for Older Adults Medicines and You: A Guide for Older Adults Council on Family Health Provided in cooperation with U.S. Department of Health and Human Services Food and Drug Administration and the Administration on Aging

More information

2016 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan

2016 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan 2016 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan Plan Details, Programs, and Policies Table of Contents Click on the links below to be taken to that

More information

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016 1 Opioid Abuse in Iowa Rx to Heroin Iowa Governor s Office of Drug Control Policy January 2016 Why Is This Important? 2 3 National Rx Painkiller Trends CDC, 2013 4 National Rx-Heroin Trends NIH, 2015 5

More information

CHAPTER 120: TOBACCO

CHAPTER 120: TOBACCO CHAPTER 120: TOBACCO Section 120.01 Definitions 120.02 Jurisdiction 120.03 Prohibitions on sale or distribution of tobacco products 120.04 Licensing of tobacco products retailers 120.99 Penalty 120.01

More information

Health Authority Abu Dhabi. Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number:

Health Authority Abu Dhabi. Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number: Health Authority Abu Dhabi Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number: PPR/DMP/DR/P0001 Version 0.9 Approval Date: August 2007 Effective Date: August 2007 Last

More information

Substance Abuse Policy. Substance Abuse Policy for Employees and Students

Substance Abuse Policy. Substance Abuse Policy for Employees and Students College Rules and Regulations 2.2008.1 Substance Abuse Policy Substance Abuse Policy for Employees and Students I. Substance Abuse Policy for Employees and Students A. Purpose The County College of Morris

More information

California. Prescribing and Dispensing Profile. Research current through November 2015.

California. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile California Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

DRUG-FREE AND ALCOHOL-FREE WORK PLACE

DRUG-FREE AND ALCOHOL-FREE WORK PLACE DRUG-FREE AND ALCOHOL-FREE WORK PLACE The following applies to all employees: 1. The Gloucester County Public School System has a vital interest in maintaining a safe, healthy, and productive environment

More information

Strategies to Manage The Opioid Crisis

Strategies to Manage The Opioid Crisis Strategies to Manage The Opioid Crisis Matt Feehery, LCDC Senior Vice President & CEO PaRC (Prevention & Recovery Center) Behavioral Health Services February 1, 2018 A Pill for Your Pain But my doctor

More information

Guidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

Guidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry DRAFT GUIDANCE This guidance

More information

Home Model Legislation Public Safety and Elections. Methamphetamine Reduction Act

Home Model Legislation Public Safety and Elections. Methamphetamine Reduction Act Search GO LOGIN LOGOUT HOME JOIN ALEC CONTACT ABOUT MEMBERS EVENTS & MEETINGS MODEL LEGISLATION TASK FORCES ALEC INITIATIVES PUBLICATIONS NEWS Model Legislation Home Model Legislation Public Safety and

More information

SUBJECT: Effective Date: Policy Number: Controlled Substance and Prescription Drugs 11/30/

SUBJECT: Effective Date: Policy Number: Controlled Substance and Prescription Drugs 11/30/ Division of Research SUBJECT: Effective Date: Controlled Substance and Prescription Drugs 11/30/2018 Supersedes: Page Of 12/04/2015 04/25/2007 1 6 Responsible Authorities: Vice President, Research Institutional

More information

MISSOURI BOARD OF PHARMACY NEWSLETTER

MISSOURI BOARD OF PHARMACY NEWSLETTER MISSOURI BOARD OF PHARMACY NEWSLETTER FEBRUARY 2018 CONTENTS FY17 Annual Report...1 What Takes So Long?...3 Did You Know?...3 Inspection Tip...3 Rule Updates...5 Meet Our New Inspector!!...6 Disciplinary

More information

Potential Solutions to Epidemic Substance Abuse in US and Europe

Potential Solutions to Epidemic Substance Abuse in US and Europe Potential Solutions to Epidemic Substance Abuse in US and Europe Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Center, Denver Health 1 Professor, University of Colorado School of Medicine

More information

H 7816 S T A T E O F R H O D E I S L A N D

H 7816 S T A T E O F R H O D E I S L A N D LC00 01 -- H 1 S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO BUSINESSES AND PROFESSIONS - PHARMACIES Introduced By: Representatives Serpa, Canario,

More information

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Tennessee Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

ORDINANCE NO

ORDINANCE NO ORDINANCE NO. 01-2017 AN ORDINANCE OF THE CITY COUNCIL OF THE CITY OF SEMINOLE, FLORIDA, REGARDING MEDICAL CANNABIS; IMPOSING A TEMPORARY MORATORIUM ON THE SALE OF MEDICAL CANNABIS AND ON THE ESTABLISHMENT

More information

Prescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study

Prescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study Prescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study Presented By: Scott McKibbin Special Advocate For Prescription Drugs State Of Illinois

More information

AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)

AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014) AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION (Moscow, 23 December 2014) Member States of the Eurasian Economic Union, hereinafter referred

More information

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: CARD/MAIL/PRE-APPROVAL/PREFERRED The Prescription Drug Coverage under this Rider [replaces] [supplements] the Prescription

More information

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH20012-MGfa-35H* (01/26)

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH20012-MGfa-35H* (01/26) H GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH0-MGfa-H* (01/) H.B. Mar, HOUSE PRINCIPAL CLERK D Short Title: Strengthen Opioid Misuse Prevention (STOP)Act. (Public) Sponsors: Referred to:

More information

Pharmacy Technician Course

Pharmacy Technician Course Pharmacy Technician Course VERSION HISTORY SECTION 1: History and Scope of the Pharmacy Technician Scope of the Pharmacy Technician Section 1 Quiz Check Your Knowledge Section 1 Quiz Answers SECTION 2:

More information

Drug and Alcohol Abuse/Prevention Policy and Program

Drug and Alcohol Abuse/Prevention Policy and Program SUPERSEDES: 09/08/2015 POLICY AND PROCEDURE MANUAL MERCY COLLEGE OF OHIO, TOLEDO, OHIO Signature: Dr. Susan Wajert, President SECTION: 500-Academic and Student Affairs CODE NO. 502 SUBJECT: Drug and Alcohol

More information

C. No employee shall report to work or remain on duty while having a detectable blood alcohol concentration.

C. No employee shall report to work or remain on duty while having a detectable blood alcohol concentration. 1 Series 3000 Personnel Section 3100 General Provisions Policy 3101 Drug Free Work Place File: 3101 3101.1 STATEMENT OF PURPOSE: The WV Board of Education and the Harrison County Board of Education recognize

More information